Pioneering Data-Driven Growth in Behavioral Health at Holmusk
In This Episode
Behavioral health has traditionally been behind in adopting precision medicine, largely due to the scarcity of robust evidence needed for informed decision-making. In this episode, Eze Abosi highlights how Holmusk is addressing this challenge by leveraging AI and real-world data to revolutionize mental health care. Eze Abosi, Chief Growth Officer at Holmusk joins Dr. Amar Drawid to explore the importance of developing standardized methods for assessing symptoms in behavioral health
- How Holmusk is generating crucial evidence that supports the development of new treatments for behavorial health.
- The functionality of Holmusk's platform technology.
- Eze's vision for advancing precision medicine in mental health care.
Transcript
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Heading 6
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Block quote
Ordered list
- Item 1
- Item 2
- Item 3
Unordered list
- Item A
- Item B
- Item C
Bold text
Emphasis
Superscript
Subscript
Our Host
Dr. Amar Drawid
Dr. Amar Drawid, an industry veteran who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
Our Speaker
Eze Abosi
Eze Abosi is the Chief Growth Officer at Holmusk, a company dedicated to transforming healthcare through real-world data, especially in behavioral health. With nearly two decades of experience in commercializing data, analytics, and consulting solutions for the life sciences industry, Eze has held key roles at companies like Optum Life Sciences, Decision Resources Group, and OptimizeRx. His expertise is in leveraging data analytics and AI to advance mental health treatment and improve patient outcomes.
.avif)
.avif)
.avif)
.avif)
.avif)